Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors.
Bioorg Med Chem Lett
; 20(14): 4065-8, 2010 Jul 15.
Article
en En
| MEDLINE
| ID: mdl-20547452
ABSTRACT
A series of HIV-1 protease inhibitors containing an epsilon substituted lysinol backbone was synthesized. Two novel synthetic routes using N-boc-L-glutamic acid alpha-benzyl ester and 2,6-diaminopimelic acid were developed. Incorporation of this epsilon substituent enabled access to the S2 pocket of the enzyme, affording high potency inhibitors. Modeling studies and synthetic efforts suggest the potency increase is due to both conformational bias and van der Waals interactions with the S2 pocket.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Inhibidores de la Proteasa del VIH
/
Lisina
Idioma:
En
Año:
2010
Tipo del documento:
Article